JPS6234058A - Method for measuring reticulocyte by flow sight meter - Google Patents

Method for measuring reticulocyte by flow sight meter

Info

Publication number
JPS6234058A
JPS6234058A JP60173009A JP17300985A JPS6234058A JP S6234058 A JPS6234058 A JP S6234058A JP 60173009 A JP60173009 A JP 60173009A JP 17300985 A JP17300985 A JP 17300985A JP S6234058 A JPS6234058 A JP S6234058A
Authority
JP
Japan
Prior art keywords
reticulocytes
fluorescence
blood cells
measuring
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60173009A
Other languages
Japanese (ja)
Other versions
JPH0464588B2 (en
Inventor
Tadahiro Takami
高見 忠弘
Takahito Fukuhara
福原 隆人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Priority to JP60173009A priority Critical patent/JPS6234058A/en
Publication of JPS6234058A publication Critical patent/JPS6234058A/en
Publication of JPH0464588B2 publication Critical patent/JPH0464588B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/012Red blood cells
    • G01N2015/014Reticulocytes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

PURPOSE:To attain to enhance the measuring accuracy of a reticulocyte, by making the amount to be used of a reagent containing auramine O more excessive than the amount precipitating RNA in a blood specimen. CONSTITUTION:When a corpuscle measuring reagent containing auramine O is mixed with an anticoagulant whole blood specimen, the auramine dye vividly stains a corpuscle containing a reticulocyte and is bonded to RNA in a cell to precipitate RNA subjected to fluorescent staining. The specimen stained with the corpuscle measuring specimen used in an amount made more excessive than the amount precipitating RNA in the blood specimen is irradiated with light of a purple - blue wavelength region to measure fluorescence from the specimen. By this method, measuring accuracy can be enhanced even with respect to a corpuscle specimen low in the concn. of a corpuscle containing a reticulocyte or having a low reticulocyte ratio.

Description

【発明の詳細な説明】 本発明はフローサイトメ) IJ−を応用した血液の光
学的測定技術特に近時その計数の重要性を増した未成熟
(網状)赤血球の測定方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an optical blood measurement technique using flow cytometry (IJ), and particularly to a method for measuring immature (reticuloid) red blood cells, whose counting has recently become increasingly important.

従来の技術 血液試料中の未成熟の赤血球は網状赤血球(レチクロサ
イトReticulocyto、 RETとも略記)と
称せられ、通常全赤血球中0.7〜2.2%がこれにあ
たシ、網状赤血球数の測定によって急性内出血、溶血性
貧血、産生不良性貧血その他の各種診断を裏付けるため
近時の臨床検査に重要視されてきた。
Conventional technology Immature red blood cells in a blood sample are called reticulocytes (reticulocytes, also abbreviated as RET), and usually account for 0.7 to 2.2% of all red blood cells. It has become important in recent clinical tests because it supports various diagnoses such as acute internal bleeding, hemolytic anemia, and hypoplastic anemia by measuring .

上記網状赤血球の計数には轟初ニューメチレンブルー、
ブリリアントクレゾールブルー等の塩基性染料により染
色された塗床血液が用いられ、全赤血球を顕微鏡で捩察
しながら発色した網状赤血球の割合を計数することが行
われた。
Todoroki Hatsume New Methylene Blue was used to count the reticulocytes mentioned above.
A blood smear stained with a basic dye such as brilliant cresol blue was used, and the percentage of colored reticulocytes was counted while all the red blood cells were twisted under a microscope.

止揚の各種染料による染色には血液試料の前処理、染色
後の目視算定に時間と労力を要し、検査数の大きい場合
に不適当であった。
Staining with various dyes requires time and labor for pre-treatment of blood samples and visual calculation after staining, making it unsuitable for large numbers of tests.

そこで開発されたフローサイトメトリーによる血液検査
は高速化、精度の向上を達成しつつあるがなお未だ網状
赤血球計数について問題が残されている。
Blood testing using flow cytometry, which was developed there, has become faster and more accurate, but problems still remain regarding reticulocyte counting.

従来技術のうち、米国特許第4,336,029号、同
第4,325,706号、同第4,284,412号は
網状赤血球の染色にアクリジンオレンジを用いることを
提案している。このアクリジンオレンジは網状赤血球中
のRNA成分に吸着されて赤色螢光を発し、緑色螢光が
主体の成熟赤血球と区別して計数可能にする。しかし、
アクリジンオレンジの場合、囚 染色溶液それ自体のバ
ックグラ/ド螢光が強く、血球由来の螢光強度測定に背
景雑音となり誤差を生じ易い、(Bl  螢光が赤色領
域の630nm以上であるため、高感度の螢光測光装置
が必要、(q 非特異染色の度合が強く、成熟赤血球の
中に赤色螢光を発生させるため、検体量誤差の小さい染
色液組成の調製が難しい、(r)I  血小板を強く染
色するため、測定中に血小板と赤血球が同時通過すると
成熟赤血球の散乱光強度と血小板の赤色螢光強度とが同
時測定され、これが網状赤血球相当の信号しにルを構成
するので誤差の原因となる、(均 アクリジンオレンジ
@液は環境依存性が大きく螢光強度が変化し易い、々ど
の問題があった。
Among the prior art, US Pat. No. 4,336,029, US Pat. No. 4,325,706, and US Pat. No. 4,284,412 propose the use of acridine orange for staining reticulocytes. This acridine orange is adsorbed to the RNA component in reticulocytes and emits red fluorescence, allowing them to be distinguished from mature red blood cells, which mainly emit green fluorescence, and to be counted. but,
In the case of acridine orange, the background fluorescence of the staining solution itself is strong, and it becomes background noise in the measurement of the fluorescence intensity derived from blood cells, which tends to cause errors. A highly sensitive fluorophotometer is required, (q) The degree of non-specific staining is strong and red fluorescence is generated in mature red blood cells, so it is difficult to prepare a staining solution composition with small sample volume error, (r)I Platelets Because red blood cells are strongly stained, if platelets and red blood cells pass simultaneously during measurement, the scattered light intensity of mature red blood cells and the red fluorescent light intensity of platelets will be measured simultaneously, and this will form a signal equivalent to reticulocytes, which can lead to errors. The cause of this problem was that the homogeneous acridine orange solution had a large environmental dependence and the fluorescence intensity was subject to change.

また、特開昭59−142465号公報においては染料
としてチオフラビンTの使用を開示している。これは、
血液試料のRNA染色を行った後希釈や洗浄によって背
景螢光及び成熟赤血球の非特異螢光を減少させたうえで
網状赤血球のRNA螢光をフローサイトメータで検出l
l′Il]定するものであるが、(目 上記希釈を通じ
て非特異螢光の低減に伴ない同時にRNA結合の染料に
よる特異螢光も低減するため、螢光感度の高い測光装置
が要求される。まだ、[Gl  希釈後は螢光強度の経
時的低下が激しくなるので再現性の高いデータが得られ
ない又(G′)染色に比較的時間がかかるという問題が
あった。
Furthermore, Japanese Patent Application Laid-Open No. 59-142465 discloses the use of Thioflavin T as a dye. this is,
After performing RNA staining of the blood sample, background fluorescence and nonspecific fluorescence of mature red blood cells are reduced by dilution and washing, and then RNA fluorescence of reticulocytes is detected using a flow cytometer.
However, as the non-specific fluorescence is reduced through the above dilution, the specific fluorescence due to the RNA-bound dye is also reduced, so a photometric device with high fluorescence sensitivity is required. However, there was still the problem that highly reproducible data could not be obtained after dilution of Gl because the fluorescence intensity decreased rapidly over time, and (G') staining took a relatively long time.

さらに、ピロニンYを染料として用いることも行われだ
が、これは固定した赤血球をRNA染色してから洗浄し
て非特異螢光及び背景螢光を完全に除いた後、RNA結
合の染料による特異螢光を測定するものである。この染
料によれば、(HJ  血球の事前固定処理、染色、洗
浄の各工程に要する時間が大きく他の方式の数十倍の所
要時間がかかるため多検体処理には適当でない、山 ピ
ロニンYそのものの螢光量子収率がきわめて低く、この
だめ高出力レーザ光源による励起によってはじめて測定
可能になる、(J)  ピロニンYは低重合度のRNA
、DNA としか結合しないので特異螢光を得るべきR
NA染色の効率が低い、などの問題があった。
Furthermore, pyronine Y has also been used as a dye, but fixed red blood cells are stained with RNA and washed to completely remove non-specific fluorescence and background fluorescence, and then specific fluorescence with an RNA-binding dye is applied. It measures light. According to this dye, (HJ) each step of pre-fixation of blood cells, staining, and washing takes a long time and is several tens of times longer than other methods, making it unsuitable for processing multiple samples. (J) Pyronine Y has an extremely low fluorescence quantum yield and can only be measured by excitation with a high-power laser light source.
, R should obtain specific fluorescence because it binds only to DNA.
There were problems such as low efficiency of NA staining.

従来使用されている70−サイドメドIj−による染色
網状赤血球計数に避は難い前述のごとき、アクリジンオ
レンジの場合の(八〜(ト)、チオフラビンTの場合の
(乃〜(α)、ピロニンYの場合の(H)〜町のすべて
の問題点を及ぶ限シ除去し得る染料物質を選択使用して
、染色試料中の網状赤血球の螢光強度を著しく増強させ
、その反面試料溶液についてはその背景螢光を低下させ
て螢光測定におけるS/N比を高め、網状赤血球の特に
低濃度又は低RET比率域での測定精度を格段に向上せ
しめることが本発明の解決しよう)する課題である。
As mentioned above, it is unavoidable to count the reticulocytes stained with the conventionally used 70-Sidemed Ij-. In case (H), the fluorescence intensity of the reticulocytes in the stained sample is significantly enhanced by selectively using a dye substance that can be removed to the extent that it covers all the problems in the sample solution, while the background of the sample solution is The problem to be solved by the present invention is to reduce fluorescence and increase the S/N ratio in fluorescence measurement, thereby significantly improving measurement accuracy of reticulocytes, especially in the low concentration or low RET ratio range.

問題点を解決するための手段 本発明は、上記の問題点を解決し、全血液試料中の赤血
球について、成熟赤血球群と未成熟赤血球であってRN
Aの多い網状赤血球群とをRET比率の多少、赤血球濃
度の大小等に影響されることなく鮮烈かつ強固な螢光染
色を網状赤血球群に施こしその染色螢光強度を著しく増
強して網状赤血球の高精度の識別を可能にするものであ
シ、そのために本発明は網状赤血球を螢光染色するため
オ−ラミンOを含有する試薬を用いること、この試薬の
使用景を試料血液中のRNA を析出せしめるよシも過
剰量とすることを特徴とするフローサイトメトリーによ
る血球測定方法を実現したものである。光学的測定に際
し血球形状を安定化させるために、塩化ナトリウム等の
アルカリ金属塩を添加して染色液試薬を等張にし、また
血液細胞の染色効率を高めるために緩衝剤を添加するこ
ともできる。
Means for Solving the Problems The present invention solves the above problems and distinguishes between mature red blood cells and immature red blood cells in a whole blood sample.
A vivid and strong fluorescent staining is applied to the reticulocyte group without being affected by the RET ratio or the red blood cell concentration, etc., and the intensity of the dyed fluorescence is significantly increased. To this end, the present invention uses a reagent containing auramine O to fluorescently stain reticulocytes, and describes the use of this reagent to identify RNA in sample blood. A method for measuring blood cells by flow cytometry is realized, which is characterized in that an excessive amount is used to precipitate the blood cells. In order to stabilize the blood cell shape during optical measurement, an alkali metal salt such as sodium chloride can be added to make the staining solution reagent isotonic, and a buffer can also be added to increase the efficiency of staining blood cells. .

螢光染料としてのオーラミンOは NH、HNO3 または NH−HIJ j が用いられる。これらのオーラミン0は染色血球に対し
て鮮明な色相を与えるとともにそれ自体の着色力も犬で
ある。
As auramine O as a fluorescent dye, NH, HNO3 or NH-HIJj is used. Auramine 0 gives a vivid hue to stained blood cells, and its coloring power is also high.

染料の分量が少なく、螢光強度が低く、かつ散乱光強度
分布にまとまシがない場合、螢光増大作用を有する固定
剤例えばグルタルアルデヒドを少の増大作用はトリトン
X−100の添加により調整し適切な検出レベルに保つ
ことが可能である。
If the amount of dye is small, the fluorescence intensity is low, and the scattered light intensity distribution is uneven, use a fixative that has a fluorescence increasing effect, such as glutaraldehyde, and adjust the increasing effect by adding Triton X-100. It is possible to maintain an appropriate detection level.

このようにして溶液の背景螢光を相対的に抑制し、さら
に網状赤血球の散乱光強度分布におけるまとまりをよく
し、これと同時に膜粘性を下げ血球相互の付着を防止し
てその弁別計数をより一層たやすくし、網状赤血球の測
定精度を格段に向上する。
In this way, the background fluorescence of the solution is relatively suppressed, and the scattered light intensity distribution of reticulocytes is improved, and at the same time, the membrane viscosity is lowered to prevent blood cells from adhering to each other, thereby improving their differential counting. This makes it easier to measure reticulocytes and significantly improves the accuracy of reticulocyte measurement.

オーラミン0は試薬1 mg当り30〜2500μ9r
の含有量が、又塩化ナトリウムなどのアルカリ金属塩は
1 rttl当り5〜20mgrでよく、pHは6−1
0に調整することが好適である。上述した組成分を有す
る等張緩衝染料溶液はEDTAなどで抗凝固化した全血
液試料と混合するための血球測定特に網状赤血球測定用
試薬となシ、本発明ではこの試薬を、検体中の血球細胞
に含まれるRNA  と化合して費消されるオーラミン
00分量を基準にしてこの基準を十分に越える過剰量の
試薬を使用することを特色とする。なお、上記試薬その
ものに関しては本出願人により特願昭60−12312
8号として出願されている。
Auramine 0 is 30-2500 μ9r per 1 mg of reagent.
The content of alkali metal salts such as sodium chloride may be 5 to 20 mgr per rttl, and the pH is 6-1.
It is preferable to adjust it to 0. The isotonic buffered dye solution having the above-mentioned composition is used as a reagent for blood cell measurement, particularly reticulocyte measurement, to be mixed with a whole blood sample anticoagulated with EDTA or the like. The method is characterized by using an excess amount of the reagent that sufficiently exceeds the amount of auramine 00 that is consumed by combining with RNA contained in cells. The above reagent itself is disclosed in Japanese Patent Application No. 60-12312 by the present applicant.
It has been filed as No. 8.

上記オーラミン0含有の血球測定用試薬を抗凝固性全血
液試料に混合すると、オーラミン染料が網状赤血球を含
宅血球をすべて鮮烈に染色して細胞中のRNA と結合
してこれを析出させ螢光染色する。このオーラミンOに
よる染色状態は、界面活性剤によシ螢光及び散乱光が共
に増強されて1時間以上持続するが、さらにアルデヒド
類による背景螢光の抑制作用が重なって、これらが綜合
され従来の試薬に比して網状赤血球の弁別計数精度は大
幅に向上する。本発明では又析出したRNAの連鎖状分
子に特異吸着された螢光染色に加え、RNAを含む他の
網状物質にオーラミンが非特異吸着される過剰量のオー
ラミンを用いており、このため網状赤血球を含む血球濃
度が低い場合や低RET比率の血液試料についても網状
赤血球の螢光強度が著しく増強されて目視計数と比べ測
定データのばらつきが殆んどなくなり診断データの高い
信頼性を与えるものとなる。染色された網状赤血球は、
アルゴンイオンレーザ、キセノ/又は水銀アークランプ
、ヘリウム−カドミウムレーザ等を好適とする励起光源
で紫色光ないし青色光を照射し発生する約450〜70
0 nm程度の螢光をフローサイトメータで検出するこ
とにより弁別計数される。この試薬によりフローサイト
メータで網状赤血球を測定する場合、その組成はオーラ
ミyO: 30〜20001’?、’/me、 Na(
J: 8〜13”+9’/rne 、グルタルアルデヒ
ド: O〜500 PI’/ ml。
When the above reagent for blood cell measurement containing auramine 0 is mixed with an anticoagulant whole blood sample, the auramine dye vividly stains all the reticulocytes and blood cells, and binds to RNA in the cells to precipitate it, causing it to fluoresce. dye. This dyed state caused by auramine O lasts for more than an hour because both fluorescence and scattered light are enhanced by the surfactant, but the background fluorescence is suppressed by the aldehydes, and these effects are combined and are The accuracy of differential counting of reticulocytes is significantly improved compared to the reagent described above. In the present invention, in addition to fluorescent staining that is specifically adsorbed to the precipitated RNA chain molecules, an excessive amount of auramine is used in which auramine is non-specifically adsorbed to other reticular substances containing RNA, and therefore, reticulocytes are Even when the blood cell concentration is low or the blood sample has a low RET ratio, the fluorescence intensity of reticulocytes is significantly enhanced, and the variation in measurement data is almost eliminated compared to visual counting, giving high reliability of diagnostic data. Become. The stained reticulocytes are
Approximately 450 to 70
Discriminative counting is performed by detecting fluorescent light of about 0 nm with a flow cytometer. When measuring reticulocytes with a flow cytometer using this reagent, its composition is OramiyO: 30-20001'? ,'/me, Na(
J: 8-13"+9'/rne, Glutaraldehyde: O-500 PI'/ml.

トリドアX −100:0〜1001”9’/rrtl
、緩衝剤としてのリン酸、ホウ酸、バルビタール:0.
01〜0.2M/l、残υ水で全体を11にしpH7,
0〜9.0に調製すると好適である。
Toridor X -100:0~1001"9'/rrtl
, phosphoric acid, boric acid, barbital as buffer: 0.
01-0.2M/l, adjust the total to 11 with remaining water and pH 7,
It is suitable to adjust it to 0 to 9.0.

作用 従来のアクリジンオレンジによる染色法では、第3図の
斜線部分の示す網状赤血球が発する螢光を全部測光する
ことが望ましいにも拘らず、網状赤血球の特異染色と成
熟赤血球や溶液自体の非特異染色が競合し成熟赤血球自
体が染色されることになり被測定波長域で重なり、この
ため網状赤血球のみを検出することができない。第3図
(1)に見る如く、成熟赤血球による背後螢光の影響を
受けることなく螢光測光ができる波長域が極めて小さい
ことが分かる。一方、網状赤血球を多く含む検体では、
試薬中の染料が一定であったため特異染色に必要な染料
が不足し、第3図(n)に示す様に網状赤血球による螢
光強度が弱小になる。また、赤血球数が少なく染料が過
剰となると共に染料が吸着しやすい血球試料の場合、第
3図(fil)に示す如く成熟赤血球、網状赤血球とも
に信号強度が増大し特異吸着の弁別が益々困難になる。
Effects In the conventional staining method using acridine orange, although it is desirable to measure all the fluorescence emitted by reticulocytes, which is shown in the shaded area in Figure 3, there is a difference between specific staining of reticulocytes and non-specific staining of mature red blood cells and the solution itself. The staining competes and mature red blood cells themselves are stained, which overlaps in the wavelength range to be measured, making it impossible to detect only reticulocytes. As can be seen in FIG. 3 (1), it can be seen that the wavelength range in which fluorescence photometry can be performed without being affected by background fluorescence from mature red blood cells is extremely small. On the other hand, in samples containing many reticulocytes,
Since the dye in the reagent was constant, there was a shortage of dye necessary for specific staining, and the intensity of fluorescence by reticulocytes became weak as shown in FIG. 3(n). In addition, in the case of a blood cell sample with a small number of red blood cells and an excess of dye, and the dye is easily adsorbed, the signal intensity of both mature red blood cells and reticulocytes increases as shown in Figure 3 (fil), making it increasingly difficult to distinguish specific adsorption. Become.

このような信号強度の泪対的変化は第4図に比較されて
いる。
Such dynamic changes in signal strength are compared in FIG.

従って、アクリジンオレンジ法では、試料中の探索する
血球数をある程度予め調整しておき、そのうえでさらて
特異吸着を最大に非特異吸着を最小(Cする染料濃度を
決定し、受光フィルター及び網、を 赤血球検知レベルの決定で再現性と精度の確認をするこ
とが必要であった。
Therefore, in the acridine orange method, the number of blood cells to be detected in the sample is adjusted to some extent in advance, and then the dye concentration that maximizes specific adsorption and minimizes non-specific adsorption (C) is determined, and the light-receiving filter and net are adjusted. It was necessary to confirm reproducibility and accuracy in determining the red blood cell detection level.

ピロニンY1チオフラビンT法ではRNAを最大染色し
た場合、第5図(1)に示す様に成熟赤血球同士の螢光
強度比が小さくしかも溶液螢光から血球信号を弁別する
ことが難しい状態になる。このため、実際の測定時は希
釈で溶液及び成熟赤血球による背後螢光を低減させてい
るが、第5図(n)に示す如(RNA 自体に基づく特
異螢光を含めて血球信号が著しく小さくなり測光に支障
を来たすに至る。
In the pyronine Y1 thioflavin T method, when RNA is stained to the maximum, the fluorescence intensity ratio between mature red blood cells is small and it is difficult to distinguish blood cell signals from solution fluorescence, as shown in FIG. 5 (1). For this reason, during actual measurements, the background fluorescence caused by the solution and mature red blood cells is reduced by dilution, but as shown in Figure 5 (n), the blood cell signal, including the specific fluorescence caused by the RNA itself, is extremely small. This may cause problems with photometry.

染料にオーラミンOを用いた場合、第1図(a)に示す
様に、溶液による背後螢光及び粘性の比較的低い成熟赤
血球などに吸着された染料による螢光強度は小さく網状
赤血球による螢光強度は相対的に太きい。従って、網状
赤血球の多い検体においてもRNAが完全に染色される
だけの染料を含有する試薬量で網状赤血球を成熟赤血球
から十分に弁別することができる。染色によって、網状
赤血球内にはRNA 、  リポソーム、ミドコンドリ
ヤ、ゴルジ体などの集積物からなる網状物質が析出沈殿
し、染料が過剰であると第1図(b)に示す如く、これ
らの物質の酸性部位に吸着され、このため、吸着された
全ての染料がRNAに吸着された(B)と同程度の高い
量子収率の光(qを発するので網状物質全体が網状赤血
球の弁別に寄与する。すなわち網状物質は第1図(b)
のB%Cの螢光強度を発生し第2図に明らかな様に溶液
及び成熟赤血球によるAをはるかにしのぐ。かくして、
オーラミン○を過剰に用いる染色で、この染料は従来法
の如く網状赤血球の測定に悪影響を及ぼすことはなく、
反対に、成熟赤血球に極めて近く網状物質それ自体の少
ない網状赤血球さえも検出可能にし、この場合測光装置
に様々な螢光感度改善策を施す必要がない。
When auramine O is used as the dye, as shown in Figure 1(a), the back fluorescence from the solution and the fluorescence intensity from the dye adsorbed to relatively low viscosity mature red blood cells are small, and the fluorescence from reticulocytes is small. The strength is relatively high. Therefore, even in a specimen containing a large amount of reticulocytes, reticulocytes can be sufficiently distinguished from mature red blood cells with an amount of reagent containing enough dye to completely stain RNA. Upon staining, reticular substances consisting of aggregates of RNA, liposomes, midochondria, Golgi bodies, etc. are deposited and precipitated within the reticulocytes. The entire reticulum contributes to the discrimination of reticulocytes since all the adsorbed dye emits light (q) with a quantum yield as high as that of the RNA adsorbed (B). In other words, the reticular substance is shown in Figure 1(b).
As is clear from FIG. 2, the fluorescence intensity of B%C is generated, which far exceeds that of A produced by solution and mature red blood cells. Thus,
This staining uses excessive amounts of auramine ○, which does not have a negative effect on reticulocyte measurements as in conventional methods.
On the contrary, it is possible to detect even reticulocytes that are very close to mature red blood cells and have little reticulum itself, and in this case there is no need to implement various measures to improve the fluorescence sensitivity of the photometric device.

実施例 オーラミンO:1.9r、塩化ナトリウム:9,9rに
o、oIM/lリン酸緩衝液と水を加えて1gとしpH
7,20の黄色の試薬を調製した。この試薬10rrt
lにEDTA抗凝固新鮮血1opz  を加え、室温で
30秒間インキュベートした後螢光フローサイトメータ
に送入した。光源は約500 nmの励起光を発生する
アルゴンイオンレーザを用い、520 nm以上の螢光
を受光検出した。前方散乱光−後方螢光で検出した網状
赤血球の含有比率の高い0.1〜26%RETの30.
t*体についてi測定した。この場合の測定データと目
視計数データとの相関は低RET試料でも極めて高かっ
た。
Example Auramine O: 1.9r, sodium chloride: 9.9r, o, oIM/l phosphate buffer and water were added to make 1g and the pH was adjusted to 1g.
A yellow reagent of 7,20 was prepared. This reagent 10rrt
1 opz of EDTA anticoagulated fresh blood was added to the tube, incubated for 30 seconds at room temperature, and then transferred to a fluorescence flow cytometer. An argon ion laser that generates excitation light of about 500 nm was used as a light source, and fluorescent light of 520 nm or more was received and detected. 30. of 0.1 to 26% RET with a high content ratio of reticulocytes detected by forward scattered light-backward fluorescence.
i measurements were made for the t* body. In this case, the correlation between the measured data and visual counting data was extremely high even for low RET samples.

効果 以上に述べた様に、オーラミン0を含有する螢光染色試
薬を血液試料に対して十分過剰量混合して染色すると次
のような螢光フローメータにとって極めて特有の効果が
もたらされる: (1)  成熟赤血球と網状赤血球との螢光強度信号差
が大きく、両者の及び溶液螢光との間の信号弁別精度が
より一層向上する。これに関連して、生成直後の未成熟
状態から次第に成熟赤血球に近づいた網状赤血球や、も
ともと血球細胞内にRNAなど網状物質が少ないもので
もこれを成熟赤血球、血小板等から高い精度で弁別し得
る。従って、低RET 比率の試料溶液で網状赤血球の
見逃しが殆んどない。
Effects As mentioned above, when a blood sample is dyed with a fluorescent staining reagent containing Auramine 0 in a sufficient excess amount, the following effects are very specific to the fluorescent flow meter: (1 ) The difference in fluorescence intensity signals between mature red blood cells and reticulocytes is large, and the accuracy of signal discrimination between both and solution fluorescence is further improved. In this regard, reticulocytes that have gradually approached mature red blood cells from an immature state immediately after generation, and even blood cells with little reticulum such as RNA, can be distinguished from mature red blood cells, platelets, etc. with high accuracy. . Therefore, in a sample solution with a low RET ratio, reticulocytes are hardly missed.

(2)染色時間が極めて短い。アクリジンオレンジ法は
5分間染色だが、RET = 2〜3%を超えると染色
終了に10分以上を要する。過剰オーラミン○による染
色ではRET=13%の検体でも30秒で完了する。
(2) Staining time is extremely short. The acridine orange method stains for 5 minutes, but when RET exceeds 2 to 3%, it takes 10 minutes or more to complete staining. Staining with excess auramine ○ can be completed in 30 seconds even for specimens with RET=13%.

(3)螢光強度が安定で染色後1時間程度は褪光し々い
から測定値の再現性・信頼性が高い。
(3) The fluorescence intensity is stable and does not easily fade for about 1 hour after staining, so the reproducibility and reliability of measured values is high.

【図面の簡単な説明】[Brief explanation of drawings]

第1図(a)は試料中の網状赤血球のRNA量と釣合う
分量のオーラミン○を含有する試薬量を用いたときの血
球細胞の螢光染色状態を示すグラフ、第1図(b+は本
発明方法により過剰量のオーラミンOを使用した染色の
示す[a)と同様のグラフ、第2図は第1図t&)、t
b)にそれぞれ対応する螢光強度の信号1.IIを比較
するグラフ、第3図(D、(II)、(Il[)はアク
リジンオレンジ法による第1図と同様のグラフ、第4図
は第3図に対応する第2図と同様のグラフ、第5図(1
1、(IDはピロニンY、チオフラビンT法による第3
図と同様のグラフである。 特許出願人 東亜医用電子株式会社 (外5名) )鼾η−−皮一長 とn〜 450  500 550  60゜ −萱光六長(nyn) 1      N 第3図 500     580     600   (77
7、?ン−V方蓑 フ11v′−倖ぜ        ツヤ器燈−準ヤ雰キ
Figure 1 (a) is a graph showing the state of fluorescent staining of blood cells when using a reagent amount containing auramine○ in an amount that is commensurate with the amount of reticulocyte RNA in the sample. A graph similar to [a) showing staining using an excess amount of auramine O by the invention method, Figure 2 is the same as Figure 1 t&), t
b) Fluorescence intensity signals corresponding to 1. Graph comparing II, Figure 3 (D, (II), (Il [)) is a graph similar to Figure 1 using the acridine orange method, Figure 4 is a graph similar to Figure 2 corresponding to Figure 3. , Figure 5 (1
1, (ID is pyronine Y, third by thioflavin T method)
This is a graph similar to the one shown in the figure. Patent Applicant Toa Medical Electronics Co., Ltd. (5 others)) Snoring η--Kichicho and n~ 450 500 550 60゜-Kayako Rokucho (nyn) 1 N Fig. 3 500 580 600 (77
7.? N-V direction fu 11v'-Kaze Tsuyakito-Quasi-Ya Atmosphere 1

Claims (1)

【特許請求の範囲】 1)オーラミンOを含有する血球用螢光染色試薬を用い
、試料血球中のRNAを析出せしめるよりも過剰量の前
記試薬によつて染色した試料に対し、紫ないし青色の波
長領域の光を光源より照射し、前記試料からの螢光を測
光することによつて網状赤血球を測定することを特徴と
する、フローサイトメータによる網状赤血球の測定方法
。 2)特許請求の範囲1記載の方法において、前記光源が
アルゴン−イオンレーザであることを特徴とするフロー
サイトメータによる網状赤血球の測定方法。 3)特許請求の範囲1記載の方法において、前記光源が
ヘリウム−カドミウムレーザであることを特徴とするフ
ローサイトメータによる網状赤血球の測定方法。 4)特許請求の範囲1記載の方法において、前記光源が
水銀アークランプであることを特徴とするフローサイト
メータによる網状赤血球の測定方法。 5)特許請求の範囲1記載の方法において、前記光源が
キセノンアークランプであることを特徴とするフローサ
イトメータによる網状赤血球の測定方法。
[Claims] 1) Using a fluorescent staining reagent for blood cells containing auramine O, a sample stained with an amount of the reagent in excess of the amount required to precipitate RNA in the sample blood cells is treated with a purple to blue color. 1. A method for measuring reticulocytes using a flow cytometer, characterized in that reticulocytes are measured by irradiating light in a wavelength range from a light source and measuring fluorescence from the sample. 2) A method for measuring reticulocytes using a flow cytometer, wherein the light source is an argon-ion laser. 3) A method for measuring reticulocytes using a flow cytometer according to claim 1, wherein the light source is a helium-cadmium laser. 4) A method for measuring reticulocytes using a flow cytometer according to claim 1, wherein the light source is a mercury arc lamp. 5) A method for measuring reticulocytes using a flow cytometer according to claim 1, wherein the light source is a xenon arc lamp.
JP60173009A 1985-08-06 1985-08-06 Method for measuring reticulocyte by flow sight meter Granted JPS6234058A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60173009A JPS6234058A (en) 1985-08-06 1985-08-06 Method for measuring reticulocyte by flow sight meter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60173009A JPS6234058A (en) 1985-08-06 1985-08-06 Method for measuring reticulocyte by flow sight meter

Publications (2)

Publication Number Publication Date
JPS6234058A true JPS6234058A (en) 1987-02-14
JPH0464588B2 JPH0464588B2 (en) 1992-10-15

Family

ID=15952502

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60173009A Granted JPS6234058A (en) 1985-08-06 1985-08-06 Method for measuring reticulocyte by flow sight meter

Country Status (1)

Country Link
JP (1) JPS6234058A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981803A (en) * 1987-07-31 1991-01-01 Toa Medical Electronics Co., Ltd. Reagent for reticulocyte counting by flow cytometry
JPH05184742A (en) * 1992-01-16 1993-07-27 Kaijirushi Hamono Kaihatsu Center:Kk Safety razor
US5260764A (en) * 1990-02-08 1993-11-09 Toa Medical Electronics Co., Ltd. Optical particle analyzing apparatus having two types of light source
EP0613003A1 (en) * 1993-02-22 1994-08-31 Toa Medical Electronics Co., Ltd. A reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same
JP2014206551A (en) * 2014-08-07 2014-10-30 ソニー株式会社 Data display method, program, data analyzing device and microparticle analysis system
US9619907B2 (en) 2010-04-28 2017-04-11 Sony Corporation Microparticle analyzing apparatus and data displaying method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336029A (en) * 1980-08-15 1982-06-22 Ortho Diagnostic Systems Inc. Method and reagents for quantitative determination of reticulocytes and platelets in whole blood

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4336029A (en) * 1980-08-15 1982-06-22 Ortho Diagnostic Systems Inc. Method and reagents for quantitative determination of reticulocytes and platelets in whole blood

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981803A (en) * 1987-07-31 1991-01-01 Toa Medical Electronics Co., Ltd. Reagent for reticulocyte counting by flow cytometry
US5260764A (en) * 1990-02-08 1993-11-09 Toa Medical Electronics Co., Ltd. Optical particle analyzing apparatus having two types of light source
JPH05184742A (en) * 1992-01-16 1993-07-27 Kaijirushi Hamono Kaihatsu Center:Kk Safety razor
EP0613003A1 (en) * 1993-02-22 1994-08-31 Toa Medical Electronics Co., Ltd. A reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same
US5470751A (en) * 1993-02-22 1995-11-28 Toa Medical Electronics Co., Ltd. Reagent for detecting malaria infected cells and a detecting method for malaria infected cells using the same
US9619907B2 (en) 2010-04-28 2017-04-11 Sony Corporation Microparticle analyzing apparatus and data displaying method
US10147209B2 (en) 2010-04-28 2018-12-04 Sony Corporation Microparticle analyzing apparatus and data displaying method
US11074727B2 (en) 2010-04-28 2021-07-27 Sony Corporation Microparticle analyzing apparatus and data displaying method
US11727612B2 (en) 2010-04-28 2023-08-15 Sony Corporation Microparticle analyzing apparatus and data displaying method
JP2014206551A (en) * 2014-08-07 2014-10-30 ソニー株式会社 Data display method, program, data analyzing device and microparticle analysis system

Also Published As

Publication number Publication date
JPH0464588B2 (en) 1992-10-15

Similar Documents

Publication Publication Date Title
EP0763201B1 (en) Detection de réticulocytes avec la Coriphosphine O
US4985174A (en) Reticulocyte quantitating reagent for flow cytometry
US5175109A (en) Reagent for classifying leukocytes by flow cytometry
US4584277A (en) Fluorescent multiparameter particle analysis
US5563070A (en) Method of counting reticulocytes
US5891733A (en) Reagent for analyzing solid components in urine and method for analyzing solid components by employing the same
KR100258394B1 (en) Methods for identifying and characterizing reticulocytes in whole blood and reagent compositions used therein
CA2068471C (en) Reagent and method for analyzing cells in urine
US4957870A (en) Detection of Reticulocytes, RNA and DNA
US4933293A (en) Method of classifying leukocytes by flow cytometry and reagents used in the method
JPH09104683A (en) Unknown compound and its use
JPS59142465A (en) Method of detecting reticulate erythrocyte
JPH0219428B2 (en)
US4707451A (en) Detection of reticulocytes
JPS6234058A (en) Method for measuring reticulocyte by flow sight meter
US20120315667A1 (en) Reagent, reagent kit and analyzing method
CN117233067B (en) A white blood cell detection kit and its application
JP4794414B2 (en) Platelet measuring reagent, platelet measuring reagent kit and platelet measuring method
MXPA96005787A (en) Detection of reticuloci

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees